These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29019614)

  • 1. Associations of serum potassium levels with mortality in chronic heart failure patients.
    Aldahl M; Jensen AC; Davidsen L; Eriksen MA; Møller Hansen S; Nielsen BJ; Krogager ML; Køber L; Torp-Pedersen C; Søgaard P
    Eur Heart J; 2017 Oct; 38(38):2890-2896. PubMed ID: 29019614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.
    Krogager ML; Torp-Pedersen C; Mortensen RN; Køber L; Gislason G; Søgaard P; Aasbjerg K
    Eur Heart J; 2017 Jan; 38(2):104-112. PubMed ID: 28158516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term prognosis of normalising serum potassium following an episode of hypokalaemia in patients with chronic heart failure.
    Aldahl M; Polcwiartek C; Davidsen L; Kragholm K; Søgaard P; Torp-Pedersen C; Krogager ML
    Eur J Prev Cardiol; 2021 Apr; 28(3):316-323. PubMed ID: 33891686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Serum Calcium Levels and Short-Term Mortality in Patients with Chronic Heart Failure.
    Jensen AC; Polcwiartek C; Søgaard P; Mortensen RN; Davidsen L; Aldahl M; Eriksen MA; Kragholm K; Torp-Pedersen C; Hansen SM
    Am J Med; 2019 Feb; 132(2):200-208.e1. PubMed ID: 30691552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.
    Collins AJ; Pitt B; Reaven N; Funk S; McGaughey K; Wilson D; Bushinsky DA
    Am J Nephrol; 2017; 46(3):213-221. PubMed ID: 28866674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs.
    Hagengaard L; Søgaard P; Espersen M; Sessa M; Lund PE; Krogager ML; Torp-Pedersen C; Kragholm KH; Polcwiartek C
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):137-144. PubMed ID: 31263883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of serum sodium levels across different serum potassium levels in heart failure patients: A Danish register-based cohort study.
    Polcwiartek C; Hansen SM; Kragholm K; Krogager ML; Aldahl M; Køber L; Torp-Pedersen C; Jensen SE; Søgaard P
    Int J Cardiol; 2018 Dec; 272():244-249. PubMed ID: 30139700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction.
    Krogager ML; Eggers-Kaas L; Aasbjerg K; Mortensen RN; Køber L; Gislason G; Torp-Pedersen C; Søgaard P
    Eur Heart J Cardiovasc Pharmacother; 2015 Oct; 1(4):245-51. PubMed ID: 27418967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
    Nakhoul GN; Huang H; Arrigain S; Jolly SE; Schold JD; Nally JV; Navaneethan SD
    Am J Nephrol; 2015; 41(6):456-63. PubMed ID: 26228532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality.
    Beusekamp JC; Tromp J; Cleland JGF; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Ouwerkerk W; van Veldhuisen DJ; Voors AA; van der Meer P
    JACC Heart Fail; 2019 Nov; 7(11):970-979. PubMed ID: 31606364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium.
    Krogager ML; Søgaard P; Torp-Pedersen C; Bøggild H; Lee CJ; Bonde A; Thomassen JQ; Gislason G; Pareek M; Kragholm K
    BMC Cardiovasc Disord; 2020 Aug; 20(1):386. PubMed ID: 32838735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Potassium Levels and Outcome in Patients With Chronic Heart Failure.
    Hoss S; Elizur Y; Luria D; Keren A; Lotan C; Gotsman I
    Am J Cardiol; 2016 Dec; 118(12):1868-1874. PubMed ID: 27726855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
    Linde C; Qin L; Bakhai A; Furuland H; Evans M; Ayoubkhani D; Palaka E; Bennett H; McEwan P
    ESC Heart Fail; 2019 Apr; 6(2):280-290. PubMed ID: 30629342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Plasma Potassium Normalization on Short-Term Mortality in Patients With Hypertension and Hyperkalemia.
    Krogager ML; Søgaard P; Torp-Pedersen C; Bøggild H; Gislason G; Kragholm K
    J Am Heart Assoc; 2020 Dec; 9(24):e017087. PubMed ID: 33317370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High- Versus Low-dose Losartan and Serum Potassium: An Analysis From HEAAL.
    Ferreira JP; Konstam M; Rossignol P; Kiernan MS; Zannad F
    J Card Fail; 2023 Jan; 29(1):45-52. PubMed ID: 36244652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between serum potassium levels and all-cause mortality in patients with acute heart failure].
    Huang BP; Zhou Q; Zhao L; Zhao XM; Zhai M; Tian PC; Liang L; Huang LY; Feng JY; Zhang YH; Huang Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(10):727-732. PubMed ID: 36889685
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom.
    Linde C; Bakhai A; Furuland H; Evans M; McEwan P; Ayoubkhani D; Qin L
    J Am Heart Assoc; 2019 Nov; 8(22):e012655. PubMed ID: 31711387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.